Page 1677 - Clinical Small Animal Internal Medicine

Index 1615

prognosis 1291–1292 iodine 78–79 KCS see keratoconjunctivitis sicca
VetBooks.ir intestinal herniation 496 IPPV see intermittent positive pressure cleaning and
IP3 see inositol triphosphate
kennels and multicat
signalment 1288–1289
environments 1063–1066
treatment 1289–1291
ventilation
intestinal intussusception 494–495, iridociliary epithelial tumors disinfection 1064–1065
495, 571 1265–1266, 1266 culture of compliance 1065
intestinal mucosal immune IRIS see International Renal Interest managing outbreaks 1065
system 628 Society modes of transmission 1063
intestinal pseudoobstruction 571 irritable bowel syndrome (IBS) 576 prevention of disease transmission
intestinal volvulus/torsion 496–497 ischemia 446 1063–1064
intraabdominal hypertension 295 ischemic stroke 785 protection from zoonotic
intraaxial hematomas 757 isolation/culture pathogens 1065–1066
intracardiac neoplasia 414–415 approach to the dermatologic risks 1063
intracellular fluid (ICF) 357, patient 1393–1394 vaccination 1064
1069–1070 bacterial infections 844–845 keratoconjunctivitis sicca
intracorporeal lithotripsy bacterial pyodermas 1468–1469 (KCS) 1047
(EHL) 1146–1147 canine distemper virus 852 Key–Gaskell syndrome 828
intracranial disease 295 fungal infections 846–847,
intracranial neoplasia see central 985–986, 998 l
nervous system tumors nonhemotropic Mycoplasma, L2‐hydroxyglutaric aciduria
intracranial pressure (ICP) Ureaplasma, and L‐form 775, 775
critical care setting 347, 350 bacteria 934, 934 lactate 406, 411
forebrain disorders 785 prostatic diseases 1159 lactulose 710, 717
head trauma 748, 749–750, protozoal and arthropod‐borne LAD see linear IgA disease
754–757 infections 843 lagenidiosis 1485–1486
vestibular disease 790 urolithiasis 1132–1133 lamellar bone 1513
intradermal allergen testing viral infections 844 laparoscopic‐assisted
1407–1408, 1407 yersiniosis 953 cystoscopy 1149
intraluminal contrast agents isoxazolines 1452–1454 laparoscopic biopsy 657–658
470–471, 470 ITP see immune‐mediated laparotomy and laparoscopy 725
intramembranous ossification thrombocytopenia large cell lymphoma 1238–1239
(IO) 1509 IVDD see intervertebral disc disease large intestine
intraocular tumors 1264–1267 IVLE see intravenous lipid emulsions cecal or colonic intussusception
diagnosis 1266 504, 504
history and clinical signs 1266 j colonic volvulus/torsion 504, 505
primary tumors 1264–1266, Jarisch–Herxheimer reaction 924 computed tomography 500, 500
1264–1266 jaundice 642, 642, 721, 723 congenital abnormalities of the
prognosis 1267 jejunal lymph nodes 492 colon 504–505
secondary uveal neoplasms 1267 jejunojejunal intussusception displacement of the colon 505
treatment 1266–1267 494–495, 495 endoscopy 522–526
intrapericardial cysts 275 J‐tubes 529 gastrointestinal imaging
intravascular contrast agents 471 junctionopathies 382 498–505, 500–505
intravenous catheters 355 justice principle 1561–1563 inflammatory disorders 500, 501
intravenous lipid emulsions juvenile cellulitis 1447–1448 intestinal cancers 1287–1292
(IVLE) 443–444 clinical signs 1447 megacolon 500–504, 502–503
intussusception diagnosis 1447–1448 pneumocolonography 499
gastroesophageal 479 pathogenesis 1447 radiography 498–500, 501–505
large intestine 504, 504 signalment 1447 tumors of the large intestine
motility disorders 571 treatment and prognosis 1448 500, 501
small intestine 494–495, 495, 571 juvenile hypoglycemia 106 ultrasonography 498–500,
invasion 1210 501, 503
IO see intramembranous ossification k laser ablation 538
iodinated contrast agents Kaplan–Meier survival curves 20–21, laser therapy 1267
470–471, 482 20, 248, 248 latex agglutination assay 993